Physicochemical Properties
| Molecular Formula | C24H18CLFEN3O |
| Molecular Weight | 455.72 |
| CAS # | 888958-26-7 |
| Appearance | Light yellow to yellow solid powder |
| SMILES | C(N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)O)CC(C)C)(=O)[C@]([H])([C@H](O)C)NC(=O)[C@H](C)NC([C@@H]1CCCN1C(=O)CNC(=O)CNC(=O)CN)=O |
| Synonyms | SARSCoVIN2; SARS CoV IN 2 |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| ln Vitro | SARS-CoV-IN-2 (compound 3) is significantly more effective than chloroquine (CQ) at preventing Plasmodium falciparum from growing in vitro [1]. |
| References |
[1]. Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. J Med Chem. 2006 May 4;49(9):2845-9. |
Solubility Data
| Solubility (In Vitro) | DMSO : ~19.23 mg/mL (~42.20 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 1.92 mg/mL (4.21 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 19.2 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1943 mL | 10.9716 mL | 21.9433 mL | |
| 5 mM | 0.4389 mL | 2.1943 mL | 4.3887 mL | |
| 10 mM | 0.2194 mL | 1.0972 mL | 2.1943 mL |